摘要
心力衰竭(简称心衰)是一个不可治愈的疾病,本文主要在细胞内信号通路水平上讨论近二十年内心衰研究的最新进展及相应的分子靶向治疗,包括针对胞内蛋白的靶向治疗、基因治疗修复缺陷酶、干细胞取代治疗等。
出处
《广东医学》
CAS
CSCD
北大核心
2013年第10期1628-1631,共4页
Guangdong Medical Journal
参考文献39
-
1PACKER M, CARVER J R, RODEHEFFER R J, et al. Effect of oral milrinone on mortality in severe chronic heart failure [ J ]. N Engl J Med, 1991, 325(21) : 1468 -1475.
-
2NIKOLAEV V D, MOSHKOV A, LYON A R, et al. Adrenergic receptor redistribution in heart failure changes cAMP compartment- ation science[J]. Science, 2010, 327(5973): 1653- 1657.
-
3PACKER M, COATS A G, FOWLER M B, et al. Effect of carve- dilol on survival on severe chronic heart failure [ J]. N Engl J Med, 2001, 344(22): 1651 -1658.
-
4LOWES B O, GILBERT E M, ABRAHAM W T, et al. Myocardi- al gene expression in dilated cardiomypothy treated with beta - blocking agents[J]. N Engl J Med, 2002, 346(18) : 1357 - 1365.
-
5NOMA T, LEMARIE A, PRASAD S V, et al. Arrestin -media- ted adrenergic receptor transactivition of the EGFR confers cardio- proteetion[J]. J Clin Invest, 2007, 117(9) : 2445 -2458.
-
6COHN G N, TOGNONI G, Valsartan Heart Failure Trial Inves- tiqators, et al. A randomized trial of the angiotensin - receptor blocker valsartan in chronic heart failure [ J]. N Engl J Med, 2001, 345(23) : 1667 - 1675.
-
7ZANNAD F, MCMURRAY J J, KRUM H, et al. Eplerenone in patients with systolic heart failure and mild symptoms [ J ]. N Engl J Med, 2011, 364(1): 11 -21.
-
8O'CONNOR C M, STARLING R C, HERNANDEZ A F, et al. Effect of nesiritide in patients with acute decompensated heart fail- ure[J]. N Engl J ned, 2011, 365(1) : 32 -43.
-
9FO0 R S, MANI K. KITSIS K V. Death begets failure in the heart[J]. J Clin Invest, 2005, 5(3) : 565 -571.
-
10NAKAYAMA H, CHEN X, BAINES C P, et al. Ca^2+ - and mi- tochondrial -dependent cardiomyocyte necrosis as a primary medi- ator of heart failure[J]. J Clin Invest, 2007, 117(9): 2445 - 2458.
同被引文献13
-
1VREDEVOE D L, WIDAWSKI M, FONAROW G C. Interleukin - 6 (IL- 6)expression and natural killer (NK) cell dysfunction and anergy in heart failure[J]. Am J Cardiol, 2004, 93(8) : 1007 - 1011.
-
2HISASHI Y, YAMADA K, KUWAKI K, et al. Rejection of cardi- ac xenografts transplanted from alpha/, 3 - galactosyltransferase gene - knockout ( GaIT - KO) pigs to baboons [ J ]. Am J Trans- plant, 2008, 8(12) : 2516 -2526.
-
3SOB1RIN M A, KINUGAWA S, TAKAHASHI M, et al. Activation of natural killer T cells ameliorates postinfarct cardiac remodeling and failure in mice[J]. Circ Res, 2012, 111(8) : 1037 -1047.
-
4YAO Izl C, LIU S Q, YU K, et al. Interleukin - 2 enhances the cy- totoxic activity of circulating natural kilter cells in patients with chronic heart failure[J]. Heart Vessels, 2009,24(4) : 283 -286.
-
5SOBIRIN M A, KINUGAWA S, TAKAHASHI M, et al. Aetiva- tion of natural killer T cells ameliorates postinfarct cardiac remode- ling and failure in mice[J]. Circ Res, 2012, 111(8):1037- 1047.
-
6BOUCHENTOUF M, FORNER K A, CUERQUIS J, et al. Induc- tion of eardiac angiogenesis requires killer eell leetin - like reeeptor1 and alpha4beta7 integrin expression by NK cells [ J]. J Immu- nol, 2010, 185(11): 7014-7025.
-
7YAO H C, LIU S Q, YU K, et al. Interleukin -2 enhances the cytotoxic activity of circulating natural killer cells in patients with chronic heart failure [ Jl. Heart Vessels, 2009, 24 (4) : 283 - 286.
-
8LI X F, CHARNOCK JONES D S, ZHANG E, et al. Angiogenie growth factor messenger ribonucleie acids in uterine natural killer cells[J]. J Clin Endocrinol Metab, 2001, 86(4) : 1823 -1834.
-
9谭晓玉.心力衰竭患者NK细胞活性变化[J].中国实验诊断学,2008,12(4):476-478. 被引量:1
-
10胡泽平,王邦宁,李嘉嘉.慢性心力衰竭患者外周血CD4^+ CD25^+ CD127^-调节性T细胞和自然杀伤细胞的变化[J].安徽医科大学学报,2010,45(1):98-101. 被引量:11
二级引证文献4
-
1葛慧娟.重组人脑利钠肽对于急性心肌梗死后老年心力衰竭患者疗效及预后的影响[J].中国老年学杂志,2016,36(3):602-604. 被引量:57
-
2李霞,陈永康.参附注射液对急性心肌梗死合并心力衰竭患者心功能的改善作用及疗效分析[J].医学综述,2016,22(15):3108-3111. 被引量:22
-
3赵思鸿,刘亮,张明旭.急性心肌梗死患者血清sST2水平的变化及其与心肌活性的相关性[J].中国循证心血管医学杂志,2017,9(6):716-718. 被引量:16
-
4赵世明.rhBNP应用对行PCI术后并发心力衰竭AMI病人心脏功能、NT-proBNP水平及死亡率的影响[J].中西医结合心脑血管病杂志,2018,16(6):760-762. 被引量:11
-
1胡江鸿,王锁荣,陆婷,臧耀华.胃癌组织中Galectin-3及Bcl-2的表达[J].苏州大学学报(医学版),2006,26(5):809-811.
-
2刘晓,刘巍.多发性骨髓瘤综合治疗现状与进展[J].现代肿瘤医学,2007,15(7):1013-1016.
-
3张伟,方克伟,吴静.白细胞介素6在前列腺癌发生发展中的作用机制研究进展[J].医学研究生学报,2016,29(11):1229-1232. 被引量:3
-
4马强,刘谦,宋娜玲.经典Wnt/β-catenin信号通路在前列腺癌治疗中的新靶点[J].肿瘤学杂志,2014,20(7):582-586. 被引量:2
-
5郭垞,侯健.多发性骨髓瘤的治疗现状与进展[J].中国实用内科杂志:临床前沿版,2006,26(6):892-894. 被引量:14
-
6储节胜,徐建明.信号通路在肝细胞性肝癌发生及靶向治疗中的作用[J].中国肿瘤临床与康复,2012,19(4):375-378. 被引量:4
-
7申利贤,周斌,李海艳,闵可,蒋敏媚,郭玉.前列腺癌发生发展相关信号转导通路的研究进展[J].肿瘤药学,2016,6(2):96-102. 被引量:11
-
8关茜,申娴娟,王旭东,鞠少卿.外泌体在肿瘤中的研究进展[J].临床检验杂志,2017,35(3):199-202. 被引量:5
-
9何文英,彭宽.流式细胞术免疫分型在急性髓细胞白血病诊断中的应用[J].实用医技杂志,2013,20(2):157-158. 被引量:1
-
10谢显彪,尹军强,贾强,王晋,邹昌业,王姚斐,黄纲,沈靖南.槲皮素诱导耐甲氨蝶呤骨肉瘤细胞系U2-OS/MTX300凋亡[J].中山大学学报(医学科学版),2011,32(3):331-335. 被引量:4